ValiRx plc (LSE:VAL) has launched a retail share offer through Winterflood’s Retail Access Platform, aiming to raise up to £150,000 through the issue of as many as 75,000,000 new ordinary shares priced at 0.2 pence each. The pricing matches that of the company’s recently completed £1.005 million placing and subscription involving institutional investors.
Retail investors offered warrants alongside new shares
Participants in the retail offer will receive one warrant for every share subscribed, with the warrants exercisable at 0.28 pence over a three-year period, subject to shareholder approval at the forthcoming annual general meeting.
The initiative broadens participation in the fundraising to include UK retail shareholders alongside institutional backers. Chief executive Mark Eccleston has also indicated his intention to subscribe for 25,000,000 shares, which the company said demonstrates management’s confidence in its strategic direction.
Funds raised through the retail offer will be applied in the same manner as the proceeds from the institutional placing, supporting the company’s capital requirements and development pipeline. Completion of the offer remains dependent on admission of the new shares to AIM and, in relation to the warrants and broker warrants, on obtaining sufficient shareholder authorities for allotment.
ValiRx’s outlook continues to be shaped by challenging financial performance, including ongoing losses and dependence on external financing. Technical indicators currently suggest a weaker market trend, although there is some potential for recovery. Valuation metrics remain under pressure due to negative earnings and the absence of dividend support.
More about ValiRx plc
ValiRx plc is an AIM-listed life sciences company focused on the development of early-stage cancer therapeutics and women’s health treatments. Its pipeline includes assets such as CLX001 and VAL201, with the business concentrating on innovative oncology and related therapies within the higher-risk, early-stage drug development sector.









